NARDINE SAWERIS: Open Payments
NPI 1437810777 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $184 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Janssen Biotech, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $39 |
| Genmab U.S., Inc. | 1 | $26 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
Products named: CALQUENCE, DARZALEX, Epkinly, XPOVIO, VENCLEXTA.
Industry payments across CA — which companies pay providers there.
